arXiv:2603.17217v1 Announce Type: cross
Abstract: Responsible use of AI demands that we protect sensitive information without undermining the usefulness of data, an imperative that has become acute in the age of large language models. We address this challenge with an on-premise, LLM-driven substitution pipeline that anonymizes text by replacing personally identifiable information (PII) with realistic, type-consistent surrogates. Executed entirely within organizational boundaries using local LLMs, the approach prevents data egress while preserving fluency and task-relevant semantics.
We conduct a systematic, multi-metric, cross-technique evaluation on the Action-Based Conversation Dataset, benchmarking against industry standards (Microsoft Presidio and Google DLP) and a state-of-the-art approach (ZSTS, in redaction-only and redaction-plus-substitution variants). Our protocol jointly measures privacy, semantic utility, and trainability under privacy via a lifecycle-ready criterion obtained by fine-tuning a compact encoder (BERT+LoRA) on sanitized text. In addition, we assess agentic Q&A performance by inserting an on-premise anonymization layer before the answering LLM and evaluating the quality of its responses. This intermediate, type-preserving substitution stage ensures that no sensitive content is exposed to third-party APIs, enabling responsible deployment of Q&A agents without compromising confidentiality.
Our method attains state-of-the-art privacy, minimal topical drift, strong factual utility, and low trainability loss, outperforming rule-based approaches and named-entity recognition (NER) baselines and ZSTS variants on the combined privacy–utility–trainability frontier. These results show that local LLM substitution yields anonymized corpora that are both responsible to use and operationally valuable: safe for agentic pipelines and suitable for downstream fine-tuning with limited degradation.
Three immunoregulatory signatures define non-productive HIV infection in CD4+ T memory stem cells
The persistent HIV reservoir constitutes the main obstacle to curing HIV/AIDS disease. Our understanding of how non-productive HIV infections are established in primary human CD4+




